i saw the interview... the other panelist was very bouyant... said MSB should be in Everyones portfolio.. a strong buy. The rerating let the dogs out with regard to further market manipulation. If covid is the health care challange of our generation (lifetime), then the companies who will and must rise to combat it are in a battle of epic proportions. MSB is rising to the fight. No time for cynicism.
i saw the interview... the other panelist was very bouyant......
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21024 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 241 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |